Gadopiclenol Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 0.25 mmol/mL
Reference Brands: Elucirem (USA), Vueway(EU)
Category:
Contrast Agent
Gadopiclenol is available in Injection
and strengths such as 0.25 mmol/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Gadopiclenol is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Gadopiclenol can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Gadopiclenol is a gadolinium-based contrast agent used in magnetic resonance imaging (MRI) to enhance the visualization of lesions and areas with abnormal vascularity in the central nervous system and throughout the body. It is a paramagnetic, macrocyclic, non-ionic complex of gadolinium, designed to improve image quality by altering the relaxation properties of nearby water protons.
Compared with standard gadolinium-based contrast agents, gadopiclenol exhibits higher relaxivity, allowing for lower administered doses while maintaining high-resolution imaging. This reduces the total gadolinium exposure to the patient, improving safety profiles while providing clear and detailed diagnostic images. Gadopiclenol is approved for use in both adults and pediatric patients, with the recommended dose being 0.05 mmol/kg, administered intravenously under the supervision of a qualified healthcare professional.
Its high efficacy, lower required dose, and favorable safety profile make gadopiclenol a valuable tool in diagnostic imaging for detecting tumors, vascular abnormalities, and other pathological conditions across multiple organ systems.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing